Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/24/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Herbert Nagasawa?

Herbert T. Nagasawa

Principal Scientist

VA Medical Center

HQ Phone:  (414) 384-2000

Email: h***@***.gov

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

VA Medical Center

5000 West National Ave.

Milwaukee, Wisconsin,53295

United States

Company Description

McGuire Veterans Affairs Medical Center is an academic tertiary care center in Richmond, Virginia, with a long-standing affiliation with Virginia Commonwealth University School of Medicine. It has an active osteoporosis program and has been a leader in the rec...more

Background Information

Employment History

Visiting Professor

Washington State University


Ad Hoc Grant Reviewer

NCI Building Systems , Inc.


Executive Scientist

Max International LLC


Affiliations

University of Minnesota

Post-doctoral Fellow In Biochemistry


NEW Technology

Founder


Education

B.S. degree

chemistry

Western Reserve University


Ph.D.


Ph.D. degree

organic chemistry

University of Minnesota


Ph.D.'s RiboCeine invention


PhD

National Institutes of Health-Homeland Security 4th Annual Countermeasures Against Chemical Threats Network Symposium


Web References(160 Total References)


TheMax4uStore MaxGXL - Max GXL

themax4ustore.com [cached]

We are very excited to announce that Max International has acquired the technology and assets behind CellGevity, a company founded in part by Dr. Herbert Nagasawa after 40 years of scientific research on Glutathione and the benefits it provides the human body.
Max International has acquired all of the assets of CellGevity including: Herbert T. Nagasawa, Ph.D.: Co-Founder, Chairman and Director of Research Chief Scientist and co-founder of CellGevity, Inc., Dr. Nagasawa received his B.S. degree in chemistry from Western Reserve University (now, Case-Western Reserve) in Cleveland, Ohio, and the Ph.D. degree in organic chemistry from the University of Minnesota. Subsequently, he spent two years as a Post-doctoral Fellow in biochemistry at the University of Minnesota before joining the research staff of the V.A. Medical Center in Minneapolis as a Senior Chemist. He was appointed Assistant Professor of Medicinal Chemistry at the University of Minnesota in 1959. He was named Principal Scientist of the VAMC in 1961 and was promoted in 1976 to Senior Research Career Scientist, a nationwide VA title reserved for the VA's top scientists. He was promoted to Associate Professor in 1963 and to Professor of Medicinal Chemistry in 1973. He also held joint professorships in the Department of Pharmacology and the university-wide Division of Toxicology, and served as Visiting Professor at Washington State University in 1990. He also served for 32 years as a Senior Editor for the prestigious international Journal of Medicinal Chemistry from 1972 to 2004, and one year as Acting Editor-in-Chief. In addition, he served on the Editorial Board of the journal, Bioconjugate Chemistry for eight years, and as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of Health. He has published over 165 papers in peer-reviewed journals, and is the inventor named on ten U.S. and PCT patent applications.


The Research Team - Alcohol GSH

alcoholgsh.com [cached]

Although Max was founded only in 2007, our growing expertise is based on more than 25 years of research performed by Dr. Herbert Nagasawa, who joined Max in 2009.
Dr. Herbert T. Nagasawa, Executive Research Scientist Dr. Nagasawa received his B.S. degree in chemistry from Western Reserve University (now, Case-Western Reserve) in Cleveland, Ohio, and a Ph.D. degree in organic chemistry from the University of Minnesota. Subsequently, he spent two years as a Post-doctoral Fellow in biochemistry at the University of Minnesota before joining the research staff of the V.A. Medical Center in Minneapolis as a Senior Chemist. He was appointed Assistant Professor of Medicinal Chemistry at the University of Minnesota in 1959. He was named Principal Scientist of the VAMC in 1961 and was promoted in 1976 to Senior Research Career Scientist, a nationwide VA title reserved for the VA's top scientists. He was promoted to Associate Professor in 1963 and to Professor of Medicinal Chemistry in 1973. He also held joint professorships in the Department of Pharmacology and the university-wide Division of Toxicology, and served as Visiting Professor at Washington State University in 1990. He also served for 32 years as a Senior Editor for the prestigious international Journal of Medicinal Chemistry from 1972 to 2004, and one year as Acting Editor-in-Chief. In addition, he served on the Editorial Board of the journal, Bioconjugate Chemistry for eight years, and as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of Health. He has published over 165 papers in peer-reviewed journals. In June of 2010, Herb attended the National Institutes of Health-Homeland Security 4th Annual Countermeasures Against Chemical Threats Network Symposium held in San Francisco. Herb and the team of scientists presented their work on the cyanide antidote. Scott, an original co-founder of CellGevity, then left to join Dr. Herb Nagasawa and Scott Momii at CellGevity, and served full-time as the Chief Technical Officer (CTO).


Max International

maxgxl.com [cached]

The creator of RiboCeine™ - Herbert T. Nagasawa, Ph.D., Executive Research Scientist
Chief Scientist and co-founder of CellGevity, Inc., Dr. Nagasawa received his B.S. degree in chemistry from Western Reserve University (now, Case-Western Reserve) in Cleveland, Ohio, and the Ph.D. degree in organic chemistry from the University of Minnesota. Subsequently, he spent two years as a Post-doctoral Fellow in biochemistry at the University of Minnesota before joining the research staff of the V.A. Medical Center in Minneapolis as a Senior Chemist. He was appointed Assistant Professor of Medicinal Chemistry at the University of Minnesota in 1959. He was named Principal Scientist of the VAMC in 1961 and was promoted in 1976 to Senior Research Career Scientist, a nationwide VA title reserved for the VA's top scientists. He was promoted to Associate Professor in 1963 and to Professor of Medicinal Chemistry in 1973. He also held joint professorships in the Department of Pharmacology and the university-wide Division of Toxicology, and served as Visiting Professor at Washington State University in 1990. He also served for 32 years as a Senior Editor for the prestigious international Journal of Medicinal Chemistry from 1972 to 2004, and one year as Acting Editor-in-Chief. In addition, he served on the Editorial Board of the journal, Bioconjugate Chemistry for eight years, and as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of Health. He has published over 165 papers in peer-reviewed journals, and is the inventor named on ten U.S. and PCT patent applications.


Max International

max4u.com [cached]

Although Max was founded only in 2007, our growing expertise is based on more than 25 years of research performed by Dr. Herbert Nagasawa, who joined Max in 2009.
Dr. Herbert T. Nagasawa, Executive Research Scientist Dr. Nagasawa received his B.S. degree in chemistry from Western Reserve University (now, Case-Western Reserve) in Cleveland, Ohio, and a Ph.D. degree in organic chemistry from the University of Minnesota. Subsequently, he spent two years as a Post-doctoral Fellow in biochemistry at the University of Minnesota before joining the research staff of the V.A. Medical Center in Minneapolis as a Senior Chemist. He was appointed Assistant Professor of Medicinal Chemistry at the University of Minnesota in 1959. He was named Principal Scientist of the VAMC in 1961 and was promoted in 1976 to Senior Research Career Scientist, a nationwide VA title reserved for the VA's top scientists. He was promoted to Associate Professor in 1963 and to Professor of Medicinal Chemistry in 1973. He also held joint professorships in the Department of Pharmacology and the university-wide Division of Toxicology, and served as Visiting Professor at Washington State University in 1990. He also served for 32 years as a Senior Editor for the prestigious international Journal of Medicinal Chemistry from 1972 to 2004, and one year as Acting Editor-in-Chief. In addition, he served on the Editorial Board of the journal, Bioconjugate Chemistry for eight years, and as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of Health. He has published over 165 papers in peer-reviewed journals. In June of 2010, Herb attended the National Institutes of Health-Homeland Security 4th Annual Countermeasures Against Chemical Threats Network Symposium held in San Francisco. Herb and the team of scientists presented their work on the cyanide antidote. Scott, an original co-founder of CellGevity, then left to join Dr. Herb Nagasawa and Scott Momii at CellGevity, and served full-time as the Chief Technical Officer (CTO).


Max Research and Developmen

prod.max.com [cached]

Max's commitment to bring the benefits of Glutathione enhancement to the world starts with our scientific research led by world-renowned medicinal chemist, Dr. Herb Nagasawa and his team.
img3 Dr. Herbert Nagasawa Dr. Nagasawa, The Father of RiboCeine™ Dr. Nagasawa Dr. Nagasawa received his B.S. degree in chemistry from Western Reserve University (now, Case-Western Reserve) in Cleveland, Ohio, and a Ph.D. degree in organic chemistry from the University of Minnesota. Subsequently, he spent two years as a Post-doctoral Fellow in biochemistry at the University of Minnesota before joining the research staff of the V.A. Medical Center in Minneapolis as a Senior Chemist. He was appointed Assistant Professor of Medicinal Chemistry at the University of Minnesota in 1959, and was named Principal Scientist of the VAMC in 1961. He was promoted in 1976 to Senior Research Career Scientist, a nationwide VA title reserved for the VA's top scientists, and was promoted in 1963 to Associate Professor of Medicinal Chemistry and to Professor in 1973.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory